137 related articles for article (PubMed ID: 17202335)
1. The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo.
Lasarte JJ; Casares N; Gorraiz M; Hervás-Stubbs S; Arribillaga L; Mansilla C; Durantez M; Llopiz D; Sarobe P; Borrás-Cuesta F; Prieto J; Leclerc C
J Immunol; 2007 Jan; 178(2):748-56. PubMed ID: 17202335
[TBL] [Abstract][Full Text] [Related]
2. Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses.
Rudilla F; Fayolle C; Casares N; Durantez M; Arribillaga L; Lozano T; Villanueva L; Pio R; Sarobe P; Leclerc C; Prieto J; Lasarte JJ
Vaccine; 2012 Apr; 30(18):2848-58. PubMed ID: 22387222
[TBL] [Abstract][Full Text] [Related]
3. A fusion protein between streptavidin and the endogenous TLR4 ligand EDA targets biotinylated antigens to dendritic cells and induces T cell responses in vivo.
Arribillaga L; Durantez M; Lozano T; Rudilla F; Rehberger F; Casares N; Villanueva L; Martinez M; Gorraiz M; Borrás-Cuesta F; Sarobe P; Prieto J; Lasarte JJ
Biomed Res Int; 2013; 2013():864720. PubMed ID: 24093105
[TBL] [Abstract][Full Text] [Related]
4. The extra domain A of fibronectin stimulates murine mast cells via toll-like receptor 4.
Gondokaryono SP; Ushio H; Niyonsaba F; Hara M; Takenaka H; Jayawardana ST; Ikeda S; Okumura K; Ogawa H
J Leukoc Biol; 2007 Sep; 82(3):657-65. PubMed ID: 17575266
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity.
Shibagaki N; Udey MC
J Immunol; 2002 Mar; 168(5):2393-401. PubMed ID: 11859130
[TBL] [Abstract][Full Text] [Related]
6. Recombinant E. coli LLO/OVA induces murine BMDCs maturation via TLR4 and NOD1 receptor and promotes specific cytotoxic T cell immunity.
Xu M; Dai MS
Biomed Environ Sci; 2010 Oct; 23(5):350-6. PubMed ID: 21112482
[TBL] [Abstract][Full Text] [Related]
7. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
8. Antigen targeting to CD11b+ dendritic cells in association with TLR4/TRIF signaling promotes strong CD8+ T cell responses.
Dadaglio G; Fayolle C; Zhang X; Ryffel B; Oberkampf M; Felix T; Hervas-Stubbs S; Osicka R; Sebo P; Ladant D; Leclerc C
J Immunol; 2014 Aug; 193(4):1787-98. PubMed ID: 25024388
[TBL] [Abstract][Full Text] [Related]
9. The adjuvanticity of a mannosylated antigen reveals TLR4 functionality essential for subset specialization and functional maturation of mouse dendritic cells.
Sheng KC; Kalkanidis M; Pouniotis DS; Wright MD; Pietersz GA; Apostolopoulos V
J Immunol; 2008 Aug; 181(4):2455-64. PubMed ID: 18684936
[TBL] [Abstract][Full Text] [Related]
10. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793
[TBL] [Abstract][Full Text] [Related]
11. Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin.
Mansilla C; Berraondo P; Durantez M; Martínez M; Casares N; Arribillaga L; Rudilla F; Fioravanti J; Lozano T; Villanueva L; Sarobe P; Borrás F; Leclerc C; Prieto J; Lasarte JJ
Int J Cancer; 2012 Aug; 131(3):641-51. PubMed ID: 21898393
[TBL] [Abstract][Full Text] [Related]
12. Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein.
Mansilla C; Gorraiz M; Martinez M; Casares N; Arribillaga L; Rudilla F; Echeverria I; Riezu-Boj JI; Sarobe P; Borrás-Cuesta F; Prieto J; Lasarte JJ
J Hepatol; 2009 Sep; 51(3):520-7. PubMed ID: 19596480
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein B binding domains: evidence that they are cell-penetrating peptides that efficiently deliver antigenic peptide for cross-presentation of cytotoxic T cells.
Sakamoto N; Rosenberg AS
J Immunol; 2011 Apr; 186(8):5004-11. PubMed ID: 21402897
[TBL] [Abstract][Full Text] [Related]
14. Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity.
Mitsui H; Okamoto T; Kanzaki M; Inozume T; Shibagaki N; Shimada S
Br J Dermatol; 2010 Jan; 162(1):29-41. PubMed ID: 19863514
[TBL] [Abstract][Full Text] [Related]
15. A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population.
Wu CC; Liu SJ; Chen HW; Shen KY; Leng CH
Oncotarget; 2016 May; 7(21):30804-19. PubMed ID: 27127171
[TBL] [Abstract][Full Text] [Related]
16. Fibronectin Containing Extra Domain A Induces Plaque Destabilization in the Innominate Artery of Aged Apolipoprotein E-Deficient Mice.
Doddapattar P; Jain M; Dhanesha N; Lentz SR; Chauhan AK
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):500-508. PubMed ID: 29326316
[TBL] [Abstract][Full Text] [Related]
17. Polyarginine-mediated protein delivery to dendritic cells presents antigen more efficiently onto MHC class I and class II and elicits superior antitumor immunity.
Mitsui H; Inozume T; Kitamura R; Shibagaki N; Shimada S
J Invest Dermatol; 2006 Aug; 126(8):1804-12. PubMed ID: 16645583
[TBL] [Abstract][Full Text] [Related]
18. A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine.
Park HJ; Jang GY; Kim YS; Park JH; Lee SE; Vo MC; Lee JJ; Han HD; Jung ID; Kang TH; Park YM
J Immunother Cancer; 2019 Feb; 7(1):60. PubMed ID: 30819254
[TBL] [Abstract][Full Text] [Related]
19. Rhamnogalacturonan II is a Toll-like receptor 4 agonist that inhibits tumor growth by activating dendritic cell-mediated CD8+ T cells.
Park SN; Noh KT; Jeong YI; Jung ID; Kang HK; Cha GS; Lee SJ; Seo JK; Kang DH; Hwang TH; Lee EK; Kwon B; Park YM
Exp Mol Med; 2013 Feb; 45(2):e8. PubMed ID: 23392255
[TBL] [Abstract][Full Text] [Related]
20. The TLR4 agonist fibronectin extra domain A is cryptic, exposed by elastase-2; use in a fibrin matrix cancer vaccine.
Julier Z; Martino MM; de Titta A; Jeanbart L; Hubbell JA
Sci Rep; 2015 Feb; 5():8569. PubMed ID: 25708982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
